All In Biotech

Drug Trial Radar · NCT06868277

A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer

A Phase III, Randomized, Double-blind, Multicenter, Global Study of Rilvegostomig or Pembrolizumab Monotherapy for the First-line Treatment of Patients With PD-L1-high Metastatic Non-small Cell Lung Cancer (ARTEMIDE-Lung04)

Last checked: Nov 20, 2026Latest source record: Sep 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 830 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

830

Planned (sponsor's estimate)

Start

Apr 10, 2025

Primary completion

Jan 17, 2030

Study completion Dec 2, 2030

Sponsor

Lead sponsor
AstraZenecaAstraZeneca (AZN)
Sponsor type
Industry
First posted
Mar 10, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of ARTEMIDE-Lung04 is to assess the efficacy and safety of rilvegostomig compared with pembrolizumab monotherapy as 1L treatment in participants with mNSCLC and whose tumors express PD-L1.

Conditions

  • Carcinoma, Non-Small Cell Lung

Interventions

  • RilvegostomigBiological

    Administered intravenously (IV) on Day 1 of each 21-day cycle

  • PembrolizumabBiological

    Administered intravenously (IV) on Day 1 of each 21-day cycle

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Overall Survival (OS)Time frame: Up to approximately 5 years
  2. Progression-Free Survival (PFS)Time frame: Up to approximately 5 years

Locations

304 sites in 27 countries. Site status is shown where the registry gives one.

  • Research Site

    La Mesa, California · Not yet recruiting

  • Research Site

    Los Alamitos, California · Not yet recruiting

  • Research Site

    Newark, Delaware · Recruiting

  • Research Site

    Bay Pines, Florida · Recruiting

  • Research Site

    Clearwater, Florida · Recruiting

  • Research Site

    Gainesville, Florida · Recruiting

  • Research Site

    St. Petersburg, Florida · Recruiting

  • Research Site

    Marietta, Georgia · Recruiting

  • Research Site

    Chicago, Illinois · Recruiting

  • Research Site

    Decatur, Illinois · Recruiting

  • Research Site

    Des Moines, Iowa · Recruiting

  • Research Site

    Waterloo, Iowa · Not yet recruiting

  • Research Site

    Leawood, Kansas · Recruiting

  • Research Site

    Lexington, Kentucky · Not yet recruiting

  • Research Site

    Owensboro, Kentucky · Recruiting

  • Research Site

    Bethesda, Maryland · Recruiting

  • Research Site

    Frederick, Maryland · Recruiting

  • Research Site

    Silver Spring, Maryland · Recruiting

  • Research Site

    Towson, Maryland · Recruiting

  • Research Site

    Saginaw, Michigan · Not yet recruiting

  • Research Site

    Bridgeton, Missouri · Recruiting

  • Research Site

    Lincoln, Nebraska · Recruiting

  • Research Site

    Reno, Nevada · Recruiting

  • Research Site

    Paramus, New Jersey · Not yet recruiting

  • Research Site

    Buffalo, New York · Recruiting

  • Research Site

    East Syracuse, New York · Recruiting

  • Research Site

    Fresh Meadows, New York · Recruiting

  • Research Site

    Rochester, New York · Not yet recruiting

  • Research Site

    Westbury, New York · Recruiting

  • Research Site

    Canton, Ohio · Not yet recruiting

  • Research Site

    Fountain Hill, Pennsylvania · Recruiting

  • Research Site

    Kittanning, Pennsylvania · Not yet recruiting

  • Research Site

    Philadelphia, Pennsylvania · Recruiting

  • Research Site

    Round Rock, Texas · Not yet recruiting

  • Research Site

    Aberdeen, Washington · Recruiting

  • Research Site

    Renton, Washington · Not yet recruiting

  • Research Site

    Charleston, West Virginia · Recruiting

  • Research Site

    Morgantown, West Virginia · Recruiting

  • Research Site

    Schofield, Wisconsin · Not yet recruiting

  • Research Site

    CABA, Argentina · Recruiting

Showing 40 of 304 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.